Eyebright Medical Technology Stock Target Price
| 688050 Stock | 90.61 1.90 2.05% |
Eyebright Medical Technology fundamentals help investors to digest information that contributes to Eyebright Medical's financial success or failures. It also enables traders to predict the movement of Eyebright Stock. The fundamental analysis module provides a way to measure Eyebright Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eyebright Medical stock.
Eyebright | Target Price |
Eyebright Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eyebright Medical's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eyebright Medical could also be used in its relative valuation, which is a method of valuing Eyebright Medical by comparing valuation metrics of similar companies.Eyebright Medical is currently under evaluation in target price category among its peers.
Eyebright Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0872 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 17.66 B | ||||
| Shares Outstanding | 189.54 M | ||||
| Shares Owned By Insiders | 38.48 % | ||||
| Shares Owned By Institutions | 20.78 % | ||||
| Price To Book | 7.52 X | ||||
| Price To Sales | 12.64 X | ||||
| Revenue | 951.18 M | ||||
| Gross Profit | 491.15 M | ||||
| EBITDA | 506.62 M | ||||
| Net Income | 304.43 M | ||||
| Total Debt | 117.94 M | ||||
| Book Value Per Share | 12.29 X | ||||
| Cash Flow From Operations | 212.62 M | ||||
| Earnings Per Share | 1.95 X | ||||
| Target Price | 115.8 | ||||
| Number Of Employees | 2.07 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 17.17 B | ||||
| Total Asset | 3.06 B | ||||
| Retained Earnings | 647.18 M | ||||
| Working Capital | 645.1 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 3.06 B | ||||
| Last Dividend Paid | 0.27 |
About Eyebright Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eyebright Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eyebright Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eyebright Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Eyebright Stock
Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.